Apremilast Tablets IP 30 Mg – ABRONIX 30 Tablets

ABRONIX 30 Tablets
Composition:- Apremilast 30 mg

ABRONIX 30 contains Apremilast Tablets IP 30 Mg, an oral phosphodiesterase-4 (PDE4) inhibitor that modulates inflammatory pathways by increasing intracellular cAMP levels. It helps reduce the production of pro-inflammatory cytokines and is indicated for the management of psoriatic conditions and inflammatory disorders.

Key Points of Apremilast Tablets IP 30 Mg – ABRONIX 30 Tablets

• Targeted Anti-Inflammatory Action: Selective PDE4 inhibition helps regulate inflammatory mediators by increasing intracellular cAMP levels, leading to a reduction in pro-inflammatory cytokines.
• Effective Symptom Control: Demonstrates efficacy in reducing redness, swelling, and plaque formation in psoriasis, while also improving joint-related symptoms in psoriatic arthritis.
• Convenient Oral Therapy: Oral administration offers ease of use with a simple dosing regimen, improving patient adherence compared to injectable therapies.

Can be Prescribed by:

• Dermatologist
• Rheumatologist
• Healthcare practitioner

Disclaimer: To be used under medical supervision only and not intended for general public promotion. This content is meant for registered healthcare professionals only.